Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant lymphoma - lymphoplasmacytic
0.010 Biomarker disease BEFREE Ibrutinib is an oral covalent inhibitor of Bruton's tyrosine kinase approved for the treatment of patients with chronic lymphocytic leukemia (CLL), mantle cell lymphoma and Waldenstrӧm's macroglobulinemia. 30785921 2019